Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Role of c-Met in cancer: emphasis on lung cancer.
SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer.
Predicting and Reducing Future Health Disparities for U.S. Adults with Diabetes
CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.
Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden.
Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden. Blood Cancer J. 2020 08 07; 10(8):81.
View in:
PubMed
subject areas
Acute Disease
Adult
Antineoplastic Agents, Immunological
Bone Marrow
Humans
Kaplan-Meier Estimate
Middle Aged
Neoplasm Recurrence, Local
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prognosis
Treatment Outcome
authors with profiles
Wendy Stock